A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 582-591

  Ni, Peihua ^a   Xu, Hong ^a   Xue, Huiping ^b   Lin, Bing ^c   Lu, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ASIA; CANCER RISK; CARDIA; DATA BASE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTESTINE; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84859743395     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1440     Document Type: Review

References (41)

1. Alpízar-Alpízar, W., Pérez-Pérez, G.I., Une, C., Cuenca, P., and Sierra, R. (2005). Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 5, 169-176.
2. Bai, X.L., Sun, L.P., Liu, J., Chen, W., Zhang, Y., and Yuan, Y. (2008). Correlation of interleukin-1 0-1 082G/a single nucleotide polymorphism to the risk of gastric cancer in North China. A case-control study. Chinese J Cancer 27, 35-40.
3. Camargo, M.C., Mera, R., Correa, P., Peek, R.M., Jr., Fontham, E.T., Goodman, K.J., Piazuelo, M.B., Sicinschi, L., Zabaleta, J., and Schneider, B.G. (2006). Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15, 1674-1687.
4. Crusius, J.B., Canzian, F., Capellá, G., Peña, A.S., Pera, G., Sala, N., Agudo, A., Rico, F., Del Giudice, G., Palli, D., Plebani, M., Boeing, H., Bueno-de-Mesquita, H.B., Carneiro, F., Pala, V., Save, V.E., Vineis, P., Tumino, R., Panico, S., Berglund, G., Manjer, J., Stenling, R., Hallmans, G., Martínez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quirós, J.R., Allen, N., Key, T.J., Binghan, S., Caldas, C., Linseisen, J., Kaaks, R., Overvad, K., Tjønneland, A., Büchner, F.C., Peeters, P.H., Numans, M.E., Clavel-Chapelon, F., Trichopoulou, A., Lund, E., Jenab, M., Rinaldi, S., Ferrari, P., Riboli, E., and González, C.A. (2008). Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 19, 1894-1902.
5. Cui, Y., Xue, H., Lin, B., Ni, P., and Fang, J.Y. (2011). A metaanalysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. DNA Cell Biol 30, 937-945.
6. De Vita, F., Orditura, M., Galizia, G., Romano, C., Infusino, S., Auriemma, A., Lieto, E., and Catalano, G. (1999). Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 86, 1936-1943.
7. Deng, W., He, L., and Peng, X. (2008). The relationship among IL-10 gene polymorphisms, H elicobacter pylori and noncardia gastric cancer development in Fujian province. Chin J Gastroenterol Hepatol 17, 212-214.
8. El-Omar, E.M., Rabkin, C.S., Gammon, M.D., Vaughan, T.L., Risch, H.A., Schoenberg, J.B., Stanford, J.L., Mayne, S.T., Goedert, J., Blot, W.J., Fraumeni, J.F., Jr., and Chow, W.H. (2003). Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124, 1193-1201.
9. García-González, M.A., Lanas, A., Quintero, E., Nicolás, D., Parra-Blanco, A., Strunk, M., Benito, R., Angel Simón, M., Santolaria, S., Sopeña, F., Piazuelo, E., Jiménez, P., Pascual, C., Mas, E., Irún, P., Espinel, J., Campo, R., Manzano, M., Geijo, F., Pellisé, M., González-Huix, F., Nieto, M., Espinós, J., Titó, L., Bujanda, L., and Zaballa, M; Spanish Gastroenterological Association AEG. (2007). Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 102, 1878-1892.
10. Guo, W., Wang, N., Wang, Y.M., Li, Y., Wen, D.G., Chen, Z.F., He, Y.T., and Zhang, J.H. (2005). Interleukin-10-1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. World J Gastroenterol 11, 858-862.
11. Heidl, G., Langhans, P., Mellin, W., Bunte, H., and Grundmann, E. (1993). Adeno-carcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 120, 95-99.
12. Hwang, I.R., Kodama, T., Kikuchi, S., Sakai, K., Peterson, L.E., Graham, D.Y., and Yamaoka, Y. (2002). Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123, 1793-1803.
13. Kamangar, F., Abnet, C.C., Hutchinson, A.A., Newschaffer, C.J., Helzlsouer, K., Shugart, Y.Y., Pietinen, P., Dawsey, S.M., Albanes, D., Virtamo, J., and Taylor, P.R. (2006). Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17, 117-125.
14. Kang, J.M., Kim, N., Lee, D.H., Park, J.H., Lee,M.K., Kim, J.S., Jung, H.C., and Song, I.S. (2009). The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 43, 420-428.
15. Kim, M.A., Lee, H.S., Yang, H.K., and Kim, W.H. (2005). Clinicopathologic and protein expression differences betweencardia carcinoma and noncardia carcinoma of the stomach. Cancer 103, 1439-1446.
16. Ko, K.P., Park, S.K., Cho, L.Y., Gwack, J., Yang, J.J., Shin, A., Kim, C.S., Kim, Y., Kang, D., Chang, S.H., Shin, H.R., and Yoo, K.Y. (2009). Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr 139, 1008-1012.
17. Lee, J.Y., Kim, H.Y., Kim, K.H., Kim, S.M., Jang, M.K., Park, J.Y., Lee, J.H., Kim, J.H., and Yoo, J.Y. (2005). Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 225, 207-214.
18. Liu, J., Song, B., Wang, J.L., Li, Z.J., Li, W.H., and Wang, Z.H. (2011). Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol 17, 1362-1367.
19. Lu, W., Pan, K., Zhang, L., Lin, D., Miao, X., and You, W. (2005). Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 26, 631-636.
20. McCarron, S.L., Edwards, S., Evans, P.R., Gibbs, R., Dearnaley, D.P., Dowe, A., Southgate, C., Easton, D.F., Eeles, R.A., and Howell, W.M. (2002). Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62, 3369-3372.
21. Mocellin, S.,Marincola, F.M., and Young, H.A. (2005). Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78, 1043-1051.
22. Morgan, D.R., Dominguez, R.L., Keku, T.O., Heidt, P.E., Martin, C.F., Galanko, J.A., Omofoye, O.A., and Sandler, R.S. (2006). Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol 4, 1103-1111.
23. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108.
24. Saito, H., Fukumoto, Y., Osaki, T., Fukuda, K., Tatebe, S., Tsujitani, S., and Ikeguchi, M. (2006). Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 30, 1864-1869.
25. Savage, S.A., Abnet, C.C., Haque, K., Mark, S.D., Qiao, Y.L., Dong, Z.W., Dawsey, S.M., Taylor, P.R., and Chanock, S.J. (2004). Polymorphisms in interleukin - 2, - 6, and - 10 are not associated with gastric cardia or esophageal cancer in a highrisk chinese population. Cancer Epidemiol Biomarkers Prev 13, 1547-1549.
26. Seifart, C., Plagens, A., Dempfle, A., Clostermann, U., Vogelmeier, C., von Wichert, P., and Seifart, U. (2005). TNFalpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21, 157-65.
27. Suerbaum, S., and Michetti, P. (2002). Helicobacter pylori infection. N Engl J Med 347, 1175-1186.
28. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Kajimura, M., Sugimura, H., and Hishida, A. (2007). Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22, 1443-1449.
29. Thakkinstian A, McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T.F., Helms, P.J., Hakonarson, H., Halpi, E., Navon, R., and Attia, J. (2005a). Systematic review and metaanalysis of the association between{h}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162, 201-211.
30. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D., and Attia, J. (2005b). A method for meta-analysis of molecular association studies. Stat Med 24, 1291-1306.
31. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J., and Hutchinson, I.V. (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24, 1-8.
32. Wu, M.S., Huang, S.P., Chang, Y.T., Shun, C.T., Chang, M.C., Lin, M.T., Wang, H.P., and Lin, J.T. (2002). Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 185, 106-109.
33. Wu, M.S., Wu, C.Y., Chen, C.J., Lin, M.T., Shun, C.T., and Lin, J.T. (2003). Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 104, 617-623.
34. Xiao, H., Jiang, Y., Li, R., and Xia, B. (2009). Association of IL-10 gene polymorphisms with gastroduodenal diseases in Hubei Han population. Chin J Med Genet 26, 423-426.
35. Xue, H., Lin, B., Ni, P., Xu, H., and Huang, G. (2010). Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol 25, 1604-1617.
36. Xue, H., Ni, P., Lin, B., Xu, H., and Huang, G. (2011). X-Ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and metaanalysis. Am J Epidemiol 173, 363-375.
37. Yang, L. (2006). Incidence and mortality of gastric cancer in China. World J Gastroenterol 12, 17-20.
38. Zambon, C.F., Basso, D., Navaglia, F., Belluco, C., Falda, A., Fogar, P., Greco, E., Gallo, N., Rugge, M., Di Mario, F., and Plebani, M. (2005). Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29, 141-152.
39. Zhou, S.Z., Zhu, W.L., Li, M.Y., Li, H.Y., and Zhang, J.R. (2008a). Association of single nucleotide polymorphism at interleukin-10 gene 1082 with the risk of gastric cancer in Chinese population. J South Med Univ 28, 1335-1338.
40. Zhou, Y., Hu, W., Zhuang, W., and Wu, X. (2011). Interleukin-10-1082 promoter polymorphism and gastric cancer risk in a Chinese Han population. Mol Cell Biochem 347, 89-93.
41. Zhou, Y., Li, N., Zhuang, W., Liu, G.J., Wu, T.X., Yao, X., Du, L., Wei, M.L., and Wu, X.T. (2008b). Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer 44, 2648-254. Review.